Completed OBSERVATIONAL NCT04265417

Clinical Outcomes and Prognostic Factors of Robotic Assisted Rectal Cancer Resection Alone vs. Robotic Rectal Cancer Resection With Natural Orifice Specimen Extraction

Sponsor: Taiyuan Li

Conditions Natural Orifice Specimen Extraction Surgery Rectal Neoplasms Robotic Surgery

Interventions Robotic Assisted Rectal Cancer Resection Alone Robotic Assisted Rectal Cancer Resection With Natural Orifice Specimen Extraction

Updated 6 times since 2020 Last updated: Feb 14, 2020 Started: Jan 6, 2015 Primary completion: Dec 1, 2016 Completion: Dec 1, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04265417, this observational or N/A phase trial focuses on Natural Orifice Specimen Extraction Surgery and Rectal Neoplasms and remains completed. Sponsored by Taiyuan Li, it has been updated 6 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 1 earlier version

Mar 2020 — Nov 2020 [monthly]

Completed

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Taiyuan Li

Data source: The First Affiliated Hospital of Nanchang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.